Form 4 · Filed Jun 17, 2026, 08:30 PM UTC
CORT/CORCEPT THERAPEUTICS INC
Mokari Atabak — Chief Financial Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
6 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | M | other | 40,000 | $19 | $770,400 | 56,130 |
| Jun 15, 2026 | S | sell | 9,434 | $80 | $754,924 | 46,696 |
| Jun 15, 2026 | S | sell | 11,081 | $81 | $896,923 | 35,615 |
| Jun 15, 2026 | S | sell | 19,483 | $82 | $1,593,889 | 16,132 |
| Jun 15, 2026 | S | sell | 2 | $82 | $165 | 16,130 |
| Jun 15, 2026 | M | other | 40,000 | — | — | 20,000 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-274224